JP2006305390A5 - - Google Patents

Download PDF

Info

Publication number
JP2006305390A5
JP2006305390A5 JP2006223635A JP2006223635A JP2006305390A5 JP 2006305390 A5 JP2006305390 A5 JP 2006305390A5 JP 2006223635 A JP2006223635 A JP 2006223635A JP 2006223635 A JP2006223635 A JP 2006223635A JP 2006305390 A5 JP2006305390 A5 JP 2006305390A5
Authority
JP
Japan
Prior art keywords
metered dose
inhalation formulation
dose inhalation
formulation
metered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006223635A
Other languages
English (en)
Other versions
JP2006305390A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2006305390A publication Critical patent/JP2006305390A/ja
Publication of JP2006305390A5 publication Critical patent/JP2006305390A5/ja
Pending legal-status Critical Current

Links

Claims (1)

  1. 明細書に記載の定量吸入処方物。
JP2006223635A 2002-08-27 2006-08-18 定量吸入処方物を産生するためのプロセス Pending JP2006305390A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40612702P 2002-08-27 2002-08-27
US42243602P 2002-10-30 2002-10-30

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2004532972A Division JP4679901B2 (ja) 2002-08-27 2003-08-26 定量吸入処方物を産生するためのプロセス

Publications (2)

Publication Number Publication Date
JP2006305390A JP2006305390A (ja) 2006-11-09
JP2006305390A5 true JP2006305390A5 (ja) 2009-12-03

Family

ID=31981380

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2004532972A Expired - Fee Related JP4679901B2 (ja) 2002-08-27 2003-08-26 定量吸入処方物を産生するためのプロセス
JP2006223635A Pending JP2006305390A (ja) 2002-08-27 2006-08-18 定量吸入処方物を産生するためのプロセス
JP2010229135A Withdrawn JP2011046726A (ja) 2002-08-27 2010-10-08 定量吸入処方物を産生するためのプロセス

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2004532972A Expired - Fee Related JP4679901B2 (ja) 2002-08-27 2003-08-26 定量吸入処方物を産生するためのプロセス

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010229135A Withdrawn JP2011046726A (ja) 2002-08-27 2010-10-08 定量吸入処方物を産生するためのプロセス

Country Status (14)

Country Link
US (3) US20040042973A1 (ja)
EP (2) EP1878664B1 (ja)
JP (3) JP4679901B2 (ja)
AT (2) ATE384001T1 (ja)
AU (1) AU2003265639A1 (ja)
CA (1) CA2495875C (ja)
CY (1) CY1107376T1 (ja)
DE (2) DE60318727T2 (ja)
DK (1) DK1542904T3 (ja)
ES (1) ES2297262T3 (ja)
MX (1) MXPA05002248A (ja)
PT (1) PT1542904E (ja)
SI (1) SI1542904T1 (ja)
WO (1) WO2004020289A1 (ja)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0207906D0 (en) 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and mometasone aerosol formulations
AU2003259986A1 (en) * 2002-08-23 2004-03-11 Schering Corporation Pharmaceutical compositions
CN1870976A (zh) * 2003-10-20 2006-11-29 先灵公司 药物组合物
SE0401408D0 (sv) * 2004-06-02 2004-06-02 Astrazeneca Ab Diameter measuring device
US9808423B2 (en) * 2004-10-12 2017-11-07 Generics [Uk] Limited Preparation of suspension aerosol formulations
US20070099883A1 (en) * 2005-10-07 2007-05-03 Cheryl Lynn Calis Anhydrous mometasone furoate formulation
US20090325917A1 (en) * 2006-10-19 2009-12-31 Cipla Limited Pharmaceutical Compositions and Nasal Spray Incorporating Anhydrous Mometasone Furoate
US20080253970A1 (en) * 2007-02-09 2008-10-16 Schering Corporation Stable Pharmaceutical Drug Products
EP2444080A3 (en) 2007-02-09 2012-05-02 Schering Corporation Stable Pharmaceutical Drug Aerosols
DK2429490T3 (en) * 2009-05-12 2017-02-20 Galenica Ab OIL-IN-WATER EMULSION OF MOMETASON
HUE027718T2 (en) 2009-05-12 2016-10-28 Galenica Ab Oil-in-water emulsion containing mometasone and propylene glycol
AU2015200276B2 (en) * 2010-02-10 2016-01-21 Astrazeneca Uk Limited A filled canister for an inhaler
BR112012019878A2 (pt) * 2010-02-10 2017-10-10 Astrazeneca Uk Ltd processo para fornecimento de um receptáculo cheio para um inalador
CN107626019A (zh) * 2016-07-18 2018-01-26 卓效医疗有限公司 手持式喷雾器
CN107951893B (zh) * 2016-10-18 2022-04-26 天津金耀集团有限公司 一种糠酸莫米松粉吸入剂组合物

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3592319A (en) * 1968-10-28 1971-07-13 Roy S Rousseau Article feed control
US3835898A (en) * 1972-11-13 1974-09-17 Kartridg Pak Co Remotely adjustable filling head
US4793461A (en) * 1987-02-26 1988-12-27 The Kartridg Pak Co. Container feed apparatus
US5143260A (en) * 1990-06-05 1992-09-01 Nozone Dispenser Systems, Inc. Aerosol adapter clamp and power system
US5182097A (en) * 1991-02-14 1993-01-26 Virginia Commonwealth University Formulations for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content
PT656207E (pt) * 1991-06-10 2001-11-30 Schering Corp Formulacoes de aerossois sem clorofluorocarbonetos
CA2111003A1 (en) * 1991-06-10 1992-12-23 Julianne Fassberg Non-chlorofluorocarbon aerosol formulations
US5275212A (en) * 1993-02-24 1994-01-04 Minnesota Mining And Manufacturing Company Aerosol filling method
GB9612297D0 (en) 1996-06-11 1996-08-14 Minnesota Mining & Mfg Medicinal aerosol formulations
US5698161A (en) 1996-08-26 1997-12-16 Michigan Critical Care Consultants, Inc. Hollow, multi-dimensional array membrane
SA97180339B1 (ar) * 1996-08-29 2006-01-31 سكيرنج كوربورشن صياغات رش هوائي مومتيازون فيورات mometasone furoate خالية من كلوروفلوروكربون chlorofluorocarbon
US6068832A (en) * 1996-08-29 2000-05-30 Schering Corporation Chlorofluorocarbon-free mometasone furoate aerosol formulations
US20060165606A1 (en) * 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6004537A (en) 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
GB9904919D0 (en) * 1999-03-03 1999-04-28 Novartis Ag Organic compounds
ES2238334T3 (es) * 1999-12-24 2005-09-01 Glaxo Group Limited Formulacion farmaceutica en aerosol de salmeterol y propionato de fluticasona.
EP1311294A2 (en) * 2000-08-04 2003-05-21 Longwood Pharmaceutical Research, Inc. Formulations of mometasone and a bronchodilator for pulmonary administration
ITMI20010428A1 (it) * 2001-03-02 2002-09-02 Chemo Breath S A Composizioni ad uso inalatorio a base di formoterolo
AR036358A1 (es) * 2001-08-28 2004-09-01 Schering Corp Un inhalador de dosis medidas que contiene una formulacion de suspension en aerosol para inhalacion, un proceso para la produccion de la formulacion, el producto y el uso de una formulacion para la manufactura de un medicamento de asma
GB0207906D0 (en) * 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and mometasone aerosol formulations
AU2003259986A1 (en) * 2002-08-23 2004-03-11 Schering Corporation Pharmaceutical compositions
CN1870976A (zh) * 2003-10-20 2006-11-29 先灵公司 药物组合物
US20070203104A1 (en) * 2006-02-09 2007-08-30 Chaudhry Saeed M Pharmaceutical Formulations
US20080253970A1 (en) * 2007-02-09 2008-10-16 Schering Corporation Stable Pharmaceutical Drug Products

Similar Documents

Publication Publication Date Title
JP2006305390A5 (ja)
DK1907037T3 (da) Medikamentdispenser.
EG25113A (en) Inhaler device counter.
IL205071A (en) Its azulcarboxamide or salt compound, a pharmaceutical product containing it and its uses
JP2006213929A5 (ja)
BRPI0810646A2 (pt) " compostos farmacêuticos ".
ZA200805953B (en) Inhaler with breath actuated dose counter
DE602006011485D1 (de) Neue dosierformulierung
ATE493119T1 (de) Pharmazeutische zusammensetzung
GB2452696B (en) 3-(2',2'-dimethylpropanoylamino)-tetrahydropyridin-2-one and its use in pharmaceutical compositions
IL209304A0 (en) Peptides, peptidomimetics and derivatives thereof, the manufacturing thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition
IL202359A0 (en) 17??-cyano-19-nor-androst-4-ene derivative, use thereof and medicaments containing said derivative
ITFI20080016A1 (it) Formulazioni farmaceutiche orali contenenti gliclazide.
EP2119720A4 (en) NEW VINBLASTINE DERIVATIVES, THEIR PREPARATION, APPLICATION AND PHARMACEUTICAL COMPOSITION CONTAINING SUCH DERIVATIVES
HK1212250A1 (en) Antiviral compounds, unit dosage form comprising said compounds and use thereof
DE602006018617D1 (de) Pharmazeutische zusammensetzung mit 2,3-dihydro-6-nitroimidazoä2,1-büoxazolderivaten
EP2192122A4 (en) Dithiolopyrrolone compounds and their preparation and use
IL202325A0 (en) 17??-cyano-19-androst-4-ene derivative, use thereof and medicaments containing said derivative
EP2309856A4 (en) PHARMACEUTICAL COMPOUNDS AS CYTOTOXICA AND ITS APPLICATION
ZA201005396B (en) 17-hydroxy-19-nor-21-carboxylic acid-steroid y-lactone derivative,use thereof,and medicament containing the derivative
ZA201005394B (en) 15,16-methylene-17-hydroxy-19-nor-21-carboxylic acid y-lactone derivative,use thereof,and medicament containing said derivative
IL195148A0 (en) 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzazepines, the preparation and use thereof and compositions containing the same
DK2029596T3 (da) 2-Alkoxy-3,4,5-trihydroxy-alkylamid-benzothiazepin, fremstilling deraf, sammensætninger indeholdende samme og anvendelse
刘捷 A Dream
TH91347B (th) ตุ๊กตา